XML 91 R55.htm IDEA: XBRL DOCUMENT
v3.25.3

INVESTMENTS (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended |
--- | --- | --- | ---
Sep. 30, 2025 | Sep. 30, 2024 | Sep. 30, 2025 | Sep. 30, 2024 | Dec. 31, 2024
Equity Method Investments and Equity Securities Without Readily Determinable Fair Value [Line Items] |  |  |  |  |
Total equity method investments | $ 362.8 |  | $ 362.8 |  | $ 321.3
Total other equity investments | 67.4 |  | 67.4 |  | 62.4
Total investments | 430.2 |  | 430.2 |  | 383.7
Earnings on investments, net | 52.7 | $ 1.0 | 48.3 | $ 29.2 |
Gain on investments |  |  | 14.5 |  |
Investment in 7Ridge Investments 3 LP |  |  |  |  |
Equity Method Investments and Equity Securities Without Readily Determinable Fair Value [Line Items] |  |  |  |  |
Total equity method investments | 362.8 |  | 362.8 |  | 321.3
Earnings on investments, net | 45.6 |  |  |  |
Investment in Japannext Co., Ltd. |  |  |  |  |
Equity Method Investments and Equity Securities Without Readily Determinable Fair Value [Line Items] |  |  |  |  |
Total other equity investments | 36.5 |  | 36.5 |  | 36.5
Investment in CSD BR |  |  |  |  |
Equity Method Investments and Equity Securities Without Readily Determinable Fair Value [Line Items] |  |  |  |  |
Total other equity investments | 10.3 |  | 10.3 |  | 5.9
Investment in Eris Innovations Holdings, LLC |  |  |  |  |
Equity Method Investments and Equity Securities Without Readily Determinable Fair Value [Line Items] |  |  |  |  |
Total other equity investments | 9.5 |  | 9.5 |  | 9.5
Investment in Talos Global, Inc. |  |  |  |  |
Equity Method Investments and Equity Securities Without Readily Determinable Fair Value [Line Items] |  |  |  |  |
Total other equity investments | 5.0 |  | 5.0 |  | 4.4
Investment in Vest Group Inc. |  |  |  |  |
Equity Method Investments and Equity Securities Without Readily Determinable Fair Value [Line Items] |  |  |  |  |
Total other equity investments | 2.9 |  | 2.9 |  | 2.9
Investment in OCC |  |  |  |  |
Equity Method Investments and Equity Securities Without Readily Determinable Fair Value [Line Items] |  |  |  |  |
Total other equity investments | 0.3 |  | 0.3 |  | 0.3
Other equity investments |  |  |  |  |
Equity Method Investments and Equity Securities Without Readily Determinable Fair Value [Line Items] |  |  |  |  |
Total other equity investments | 2.9 |  | $ 2.9 |  | $ 2.9
Investment in CSD BR and Talos Global Inc. |  |  |  |  |
Equity Method Investments and Equity Securities Without Readily Determinable Fair Value [Line Items] |  |  |  |  |
Gain on investments | $ 5.0 |  |  |  |

X
- Definition [Line Items] for Schedule of Cost and Equity Method Investments [Table] + References No definition available. + Details
Name: | cboe_EquityMethodInvestmentsAndEquitySecuritiesWithoutReadilyDeterminableFairValueLineItems
Namespace Prefix: | cboe_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 270 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (ee) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(10)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 25 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 + Details
Name: | us-gaap_EquityMethodInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of investment in equity security without readily determinable fair value. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 321 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479536/321-10-50-3 + Details
Name: | us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of gain from upward price adjustment on investment in equity security without readily determinable fair value. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 321 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479536/321-10-50-3 + Details
Name: | us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of gain (loss) included in earnings for investments classified as other. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (b) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28 + Details
Name: | us-gaap_GainLossOnSaleOfOtherInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of investment in equity method investee and investment in and advance to affiliate. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(18)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cboe_InvestmentIn7RidgeInvestments3LPMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cboe_InvestmentInJapannextCo.Ltd.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cboe_InvestmentInCSDBRMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cboe_InvestmentInErisInnovationsHoldingsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cboe_InvestmentInTalosGlobalInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cboe_InvestmentInCboeVestFinancialGroupInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cboe_InvestmentInOCCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cboe_OtherEquityInvestmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cboe_InvestmentInCSDBRAndTalosGlobalInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |